Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

E Buck, A Eyzaguirre, S Barr, S Thompson… - Molecular cancer …, 2007 - AACR
Overexpression and enhanced activation of the epidermal growth factor receptor (EGFR) is
frequently observed in human carcinomas. Inhibitors of EGFR signaling have shown clinical …
被引用次数：256 相关文章

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

E Buck, A Eyzaguirre, S Barr, S Thompson… - Molecular Cancer …, 2007 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Overexpression and enhanced activation of
the epidermal growth factor receptor (EGFR) is frequently observed in human carcinomas …
[PDF] academia.edu

[PDF][PDF] Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

E Buck, A Eyzaguirre, S Barr, S Thompson… - Mol Cancer …, 2007 - academia.edu
Overexpression and enhanced activation of the epidermal growth factor receptor (EGFR) is
frequently observed in human carcinomas. Inhibitors of EGFR signaling have shown clinical …
[PDF] researchgate.net

[PDF][PDF] Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

E Buck, A Eyzaguirre, S Barr, S Thompson… - Mol Cancer …, 2007 - researchgate.net
Overexpression and enhanced activation of the epidermal growth factor receptor (EGFR) is
frequently observed in human carcinomas. Inhibitors of EGFR signaling have shown clinical …

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition.

E Buck, A Eyzaguirre, S Barr, S Thompson… - Molecular Cancer …, 2007 - europepmc.org
Overexpression and enhanced activation of the epidermal growth factor receptor (EGFR) is
frequently observed in human carcinomas. Inhibitors of EGFR signaling have shown clinical …

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

E Buck, A Eyzaguirre, S Barr… - Molecular cancer …, 2007 - pubmed.ncbi.nlm.nih.gov
Overexpression and enhanced activation of the epidermal growth factor receptor (EGFR) is
frequently observed in human carcinomas. Inhibitors of EGFR signaling have shown clinical …

[引用][C] Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

E BUCK - Mol Cancer Theor, 2007 - cir.nii.ac.jp
Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits
sensitivity to epidermal growth factor receptor inhibition | CiNii Research CiNii 国立情報学 …